Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Muhsen, Ibrahim N  [Clear All Filters]
2023
Mina SA, Muhsen IN, Hashmi SK. Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease. Curr Opin Hematol. 2023;30(1):22-27.
Gurnari C, Spadea M, Muratori R, Jimenez V, Radici V, Torrado S, Desai N, Ropero J, Muhsen IN, Ibrahimova A, et al. Inequalities in the career pathway for paediatric HSCT and cellular therapy physicians. Lancet Haematol. 2023;10(7):e492-e494.
Mushtaq AHassan, Shafqat A, Salah HT, Hashmi SK, Muhsen IN. Machine learning applications and challenges in graft-versus-host disease: a scoping review. Curr Opin Oncol. 2023;35(6):594-600.
Haque E, Muhsen IN, Rasheed W, Fakih REl, Aljurf M. Parasitic infections in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2023:e14160.
Hashmi SK, Powles RC, Ma D, Muhsen IN, Aljurf M, Niederwieser D, Weisdorf DJ, Koh MBC, Greinix H. Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?. Ann Hematol. 2023.
Yang EH, Muhsen IN, Samarkandi H, Fakih REl, Aljurf M, Hanbali A. Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases. Hematol Oncol Stem Cell Ther. 2023;17(1):4-12.
2021
Muhsen IN, Rasheed OW, Habib EA, Alsaad RK, Maghrabi MK, Rahman MA, Sicker D, Wood WA, Beg MS, Sung A, et al. Current status and future perspectives on the Internet of Things in oncology. Hematol Oncol Stem Cell Ther. 2021.
2020
Mannan A, Muhsen IN, Barragán E, Sanz MA, Mohty M, Hashmi SK, Aljurf M. Genotypic and phenotypic characteristics of acute promyelocytic leukemia translocation variants. Hematol Oncol Stem Cell Ther. 2020.